Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?

摘要

Background.?Both endothelin receptor type B ([ET_BR], a G protein-coupled receptor that mediates the vascular effects of the potent vasoconstrictor endothelin-1) and human cytomegalovirus ([HCMV], a ubiquitous herpesvirus) have been implicated in the pathogenesis of cardiovascular disease (CVD). The effects of HCMV infection on ET_BR expression are unknown. We hypothesized that HCMV may contribute to the pathogenesis of CVD via ET_BR modulation. Methods.?Human CMV effects on ET_BR were studied in vitro in endothelial cells (ECs) and smooth muscle cells (SMCs) and ex vivo in human carotid plaque tissue specimens. Expression of ET_BR and viral immediate-early were quantified using quantitative polymerase chain reaction. Functional consequences after ET_BR blockade in ECs were examined by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide proliferation, wound healing, tube formation, and flow adhesion assays. Results.?Human CMV is capable of upregulating both ET_BR mRNA and protein expression in ECs and SMCs. The ET_BR was also abundantly expressed in ECs, foam cells, and SMCs, and, more importantly, in HCMV-positive cells in human carotid plaques. Endothelin receptor type B blockade led to decreased proliferation and reduced tumor necrosis factor α-mediated leukocyte recruitment in both uninfected and HCMV-infected ECs. Direct HCMV infection was antimigratory and antiangiogenic in ECs. Conclusions.?Human CMV may contribute to CVD via ET_BR induction.